Aisha Latif

Cell Therapy Workflow Leader

[Aisha Latif @AshAtWorkWork]

Want reliable scaling results on the first try?
See for yourself how our WAVE bioreactor on our bioreactor scaler tool can help you save time and resources!

https://t.co/2otFdGtJ5I

[Aisha Latif @AshAtWorkWork]

Be an imaging pro! Receive 15% off on imaging instruments, including the ImageQuant 800 and Typhoon systems.

You'll also receive a complimentary ImageQuant 800 Lego model! https://t.co/PWiPT0DkE3

#imagingtechnology
#lifesciences
#biopharma

[Aisha Latif @AshAtWorkWork]

Discover the Imaging Pro advantage from Cytiva!

Get up to 15% off on Typhoon and ImageQuant 800 instruments when you request a quote - plus we'll throw in a free ImageQuant 800 Lego model.
https://t.co/JmrYl34VGc

[Aisha Latif @AshAtWorkWork]

Get your team up to speed on cell therapy development and manufacturing. Register for our free online cell therapy introductory course — eCELLT1 — where you'll learn GMP techniques and how to optimize your processes. https://t.co/wUNcjs3lJA

#celltherapydevelopment

[Aisha Latif @AshAtWorkWork]

Ever wondered how manufacturers went from producing zero mRNA vaccines per year to producing millions? Katarina Stenklo pulls back the curtain on the rapid scale-up of nucleic acid therapeutics. https://t.co/Wria3X8awT

#nucleicacidtherapeutics
#mRNA
#oligos

[Aisha Latif @AshAtWorkWork]

With its broad range of applications, from early process development to late-stage scale-up, troubleshooting, and CMC, it’s the ultimate tool for optimizing your chromatography processes.

Learn more: https://t.co/8YLaT0WQAV

#insilico #chromatography #ChromatographyModeling

[Aisha Latif @AshAtWorkWork]

We interviewed our colleague George White to learn about his role in moving our business towards #celltherapy development when the viability of such therapies was far from certain. Here's what he had to say: https://t.co/t4ZJ2KeTCN

#cellandgenetherapy
#CART

[Aisha Latif @AshAtWorkWork]

Who's up for a bit of summer reading? Take our quiz to test your grasp of antibody variants, antibody domains, and considerations for setting up purification protocols. Then, download our eBook to enhance your knowledge. https://t.co/LkTctFh8LG

#mAbs
#antibodies
#biologics

[Aisha Latif @AshAtWorkWork]

Liquid biopsy is the topic of this episode. How can these biopsies find biomarkers for disease in a less invasive manner? Let’s find out. https://t.co/tHTvSXWnQ9

#liquidbiopsy
#DiscoveryMatters
#biomarkers

[Aisha Latif @AshAtWorkWork]

Watch our on-demand webinar featuring Alex de Winter and Sabrina Carmichael who share insights and answer questions on manufacturing and funding challenges #translationalresearchers need to consider. https://t.co/xyXHLaph5v

#translationalmedicine
#biomanufacturing

[Aisha Latif @AshAtWorkWork]

Our resolution for 2023 and beyond is to help you get your team up to speed on #celltherapy. Register your staff today for our free Online Advanced eCELLT1 course. https://t.co/7f35iPecpN

#professionaldevelopment

[Aisha Latif @AshAtWorkWork]

This fixed-bed bioreactor system will help you to gain productivity without increasing the footprint of your industrialization of animal cell culture processes.

https://t.co/BEJCmiip9v

#bioreactor
#lifesciences
#bioprocessing

[Aisha Latif @AshAtWorkWork]

Cytiva translational medicine advisor, Preston Keller, explores the impact of regulatory considerations, GMP manufacturing, and more on translational research and the development of novel therapeutics. Use the link to get in touch with Preston: https://t.co/3nuPfpntm8

[Aisha Latif @AshAtWorkWork]

Cytiva's innovative Protein Select technology is designed to streamline and accelerate recombinant protein purification. https://t.co/lYYz72J4N4

[Aisha Latif @AshAtWorkWork]

Asia-Pacific has emerged as the second largest region for ATMP trials, surpassing Europe as governments across Singapore, South Korea, Australia actively back up the mRNA innovation. https://t.co/CjnYkuPxsk

[Aisha Latif @AshAtWorkWork]

Cytiva's innovative Protein Select technology is designed to streamline and accelerate recombinant protein purification. https://t.co/lYYz72J4N4

[Aisha Latif @AshAtWorkWork]

As antibiotics lose efficacy, phage viruses could be the answer. Read the article to learn more: https://t.co/LGAORygiCV

#antibioticresistance
#biopharma

[Aisha Latif @AshAtWorkWork]

Cytiva's Andrew Schulman discusses why the biotechnology industry must continue working to advance allogeneic cell therapies. #celltherapies #genomicmedicine #cytiva https://t.co/96RJq9XDIH

[Aisha Latif @AshAtWorkWork]

With smaller batches and more personalized medicines on the rise, the industry's ability to produce advanced therapies at scale gets more challenging. Our flexible approach to aseptic filling in biomanufacturing aims to change that. https://t.co/5Y2Eke4U21

#precisionmedicine

[Aisha Latif @AshAtWorkWork]

Antisense technology is allowing the n-Lorem foundation to develop treatments for ultra-rare patients with genetic mutations. Connor is one of those patients awaiting his therapy. https://t.co/VaRN9fauXr

#rarediseases
#genetics